WG
ENTA icon

Winton Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Winton Group’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,489
Closed -$880K – 1121
2021
Q3 		$880K Sell
15,489
-2,602
-14% -$129K 0.05% 568
2021
Q2 		$796K Sell
18,091
-1,633
-8% -$80K 0.04% 654
2021
Q1 		$973K Buy
19,724
+358
+2% +$17.9K 0.06% 476
2020
Q4 		$815K Sell
19,366
-24,536
-56% -$1.08M 0.06% 515
2020
Q3 		$2.01M Sell
43,902
-67,867
-61% -$3.29M 0.07% 525
2020
Q2 		$5.61M Sell
111,769
-13,703
-11% -$709K 0.14% 173
2020
Q1 		$6.45M Sell
125,472
-12,508
-9% -$667K 0.17% 163
2019
Q4 		$8.52M Buy
137,980
+134,298
+3,647% +$8.33M 0.12% 290
2019
Q3 		$221K Sell
3,682
-2,413
-40% -$179K ﹤0.01% 1369
2019
Q2 		$514K Buy
6,095
+1,539
+34% +$138K 0.01% 674
2019
Q1 		$435K Buy
4,556
+1,054
+30% +$94.5K 0.01% 639
2018
Q4 		$248K Sell
3,502
-1,175
-25% -$90.1K 0.01% 730
2018
Q3 		$400K Sell
4,677
-37,330
-89% -$3.74M 0.01% 713
2018
Q2 		$4.87M Buy
42,007
+37,231
+780% +$3.71M 0.12% 285
2018
Q1 		$386K Buy
+4,776
New +$368K 0.01% 882

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Winton Group's ENTA Position: Q4 2021 in Review

Winton Group sold out of Enanta Pharmaceuticals (ENTA) in Q4 2021, closing a stake of 15,489 shares — an estimated $880K sold.

Winton Group first reported a position in ENTA in Q1 2018 and held it in 15 quarters. The position peaked at $8.52M in Q4 2019. 179 funds tracked by Wall St. Rank hold ENTA as of Q4 2021.

  • Winton Group reported no remaining Enanta Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 15,489 Enanta Pharmaceuticals shares in Q4 2021, an estimated $880K.
  • Winton Group first reported a position in Enanta Pharmaceuticals in Q1 2018 and held it in 15 quarters.
  • Winton Group's Enanta Pharmaceuticals position peaked at $8.52M in Q4 2019.
  • 179 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.